Successful thrombolysis with recombinant tissue plasminogen activator after antagonizing dabigatran by idarucizumab: a case report

BACKGROUND: Effective anticoagulation routinely precludes patients from receiving intravenous thrombolysis with recombinant tissue plasminogen activator to reverse severe symptoms of ischemic stroke. We report what we believe to be the first case of ischemic stroke successfully treated with recombin...

Descripción completa

Detalles Bibliográficos
Autores principales: Gawehn, Annemarie, Ayari, Yassine, Heuschkel, Christian, Kaste, Matthias, Kermer, Pawel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043591/
https://www.ncbi.nlm.nih.gov/pubmed/27686252
http://dx.doi.org/10.1186/s13256-016-1050-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5043591/
https://www.ncbi.nlm.nih.gov/pubmed/27686252
http://dx.doi.org/10.1186/s13256-016-1050-0

Ejemplares similares